Infermedica raised €8.6M in a Series A round in Aug 2020. The company is based in Warsaw, Poland. Investors in the round: European Bank for Reconstruction and Development, Heal Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
